Quality Assurance Scheme Development Group
The Quality Assurance Scheme Development Group (QASDG) will develop the European Quality Assurance Scheme for Breast Cancer Services (the European QA scheme) to set common quality and safety requirements for person-centred breast cancer services in Europe. The scheme will cover all the processes of breast cancer care (screening, diagnosis, treatment, rehabilitation & supportive care, follow-up & survivorship care and palliative care) and will be underpinned by the accreditation legal framework and evidence from guidelines.
The QASDG discusses and selects the requirements within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before piloting are subject of open calls for feedback launched online. After piloting, the so validated scheme will become operative on voluntary basis throughout Europe.
The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care).
The QASDG is supported by the external contractors EA- European Co-operation for Accreditation for the accreditation legal framework and for the coordination of national accreditation bodies, by CCIb –Iberoamerican Cochrane Centre for literature review and by IQ healthcare to develop indicators.
Members and external experts
Professor Bettina Borisch, Geneva (Switzerland)
Professor of Public Health, Institute of Global Health, University of Geneva
Director of the World Federation of Public Health Associations, headquartered in Geneva
Dr Borisch is an MD and a Histopathologist, MPH and Fellow of the Royal College of Pathology (UK). Her scientific research work delves into neoplastic lesions of the immune system and breast cancer. Her interests also include community-based oncology, health communication and global health.
She studied medicine and history at the Universities of Kiel (Germany) and Lausanne (Switzerland). She is appointed professor and head of the Institute of Clinical Pathology / University of Geneva in 1995. She becomes the president of the Swiss Cancer League’s program against breast cancer. She completes an MPH in 2005 and orientates her activities to Public Health and Global Health. She joins the Institute of Social and Preventive Medicine in 2005 (from 2015 on: Institute of Global Health.
She is Editor in Chief of „Pathobiology“ and the Co-Editor of „Journal of Public Health Policy“. In addition to her academic work she acts as the Director and Head of the World Federation of Public Health Associations and holds positions at several Committees of Public Health oriented institutions.She was president of Europa Donna – The European Breast Cancer Forum and Founding President of the Swiss Forum of Europa Donna. She teaches at the University of Geneva, the Swiss School of Public Health and she also teaches patient support groups. She is (co)author of over 120 scientific papers.